STAT+: Pharma wins a round in a battle with HHS over a drug discount program for hospitals

In a victory for the pharmaceutical industry, a federal judge temporarily blocked the federal government from imposing a hotly contested rule for handling disputes over a program that provides discounted drugs to hospitals and clinics serving mostly low-income populations.

The ruling granted a preliminary injunction sought by Eli Lilly (LLY), which filed a lawsuit arguing the Department of Health and Human Services improperly implemented a rule in attempting to settle a clash between several drug makers and hospitals.

Continue to STAT+ to read the full story…

STAT+: Pharma wins a round in a battle with HHS over a drug discount program for hospitals

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top